Unknown

Dataset Information

0

Effects of duloxetine and WAY100635 on pudendal inhibition of bladder overactivity in cats.


ABSTRACT: This study was aimed at determining the effect of duloxetine (a serotonin-norepinephrine reuptake inhibitor) on pudendal inhibition of bladder overactivity. Cystometrograms were performed on 15 cats under ?-chloralose anesthesia by infusing saline and then 0.25% acetic acid (AA) to induce bladder overactivity. To inhibit bladder overactivity, pudendal nerve stimulation (PNS) at 5 Hz was applied to the right pudendal nerve at two and four times the threshold (T) intensity for inducing anal twitch. Duloxetine (0.03-3 mg/kg) was administered intravenously to determine the effect on PNS inhibition. AA irritation significantly (P < 0.01) reduced bladder capacity to 27.9 ± 4.6% of saline control capacity. PNS alone at both 2T and 4T significantly (P < 0.01) inhibited bladder overactivity and increased bladder capacity to 83.6 ± 7.6% and 87.5 ± 7.7% of saline control, respectively. Duloxetine at low doses (0.03-0.3 mg/kg) caused a significant reduction in PNS inhibition without changing bladder capacity. However, at high doses (1-3 mg/kg) duloxetine significantly increased bladder capacity but still failed to enhance PNS inhibition. WAY100635 (N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridyl)cyclohexanecarboxamide; a 5-HT1A receptor antagonist, 0.5-1 mg/kg i.v.) reversed the suppressive effect of duloxetine on PNS inhibition and significantly (P < 0.05) increased the inhibitory effect of duloxetine on bladder overactivity but did not enhance the effect of PNS. These results indicate that activation of 5-HT1A autoreceptors on the serotonergic neurons in the raphe nucleus may suppress duloxetine and PNS inhibition, suggesting that the coadministration of a 5-HT1A antagonist drug might be useful in enhancing the efficacy of duloxetine alone and/or the additive effect of PNS-duloxetine combination for the treatment of overactive bladder symptoms.

SUBMITTER: Reese J 

PROVIDER: S-EPMC4019320 | biostudies-literature | 2014 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Effects of duloxetine and WAY100635 on pudendal inhibition of bladder overactivity in cats.

Reese Jeremy J   Xiao Zhiying Z   Schwen Zeyad Z   Matsuta Yosuke Y   Shen Bing B   Wang Jicheng J   Roppolo James R JR   de Groat William C WC   Tai Changfeng C  

The Journal of pharmacology and experimental therapeutics 20140325 3


This study was aimed at determining the effect of duloxetine (a serotonin-norepinephrine reuptake inhibitor) on pudendal inhibition of bladder overactivity. Cystometrograms were performed on 15 cats under α-chloralose anesthesia by infusing saline and then 0.25% acetic acid (AA) to induce bladder overactivity. To inhibit bladder overactivity, pudendal nerve stimulation (PNS) at 5 Hz was applied to the right pudendal nerve at two and four times the threshold (T) intensity for inducing anal twitch  ...[more]

Similar Datasets

| S-EPMC5866366 | biostudies-other
| S-EPMC5402006 | biostudies-literature
| S-EPMC7745638 | biostudies-literature
| S-EPMC7806916 | biostudies-literature
| S-EPMC5050417 | biostudies-literature
| S-EPMC7685239 | biostudies-literature
| S-EPMC5930411 | biostudies-literature
| S-EPMC3726658 | biostudies-literature
| S-EPMC7147252 | biostudies-literature
2018-02-09 | PXD007571 | Pride